Inari Medical Stock Gets RS Rating Upgrade

Blockhead

2024-12-12

On Wednesday, Inari Medical (NARI) stock received an upgrade to its Relative Strength (RS) Rating, from 65 to 72.

↑ X

RS Line vs. RS Rating: Which Is The Better Stock Indicator?

See All Videos

NOW PLAYING RS Line vs. RS Rating: Which Is The Better Stock Indicator?

This proprietary rating measures technical performance by showing how a stock's price action over the last 52 weeks compares to that of the other stocks in our database.

Over 100 years of market history shows that the best-performing stocks tend to have an RS Rating north of 80 as they launch their largest climbs. See if Inari Medical stock can continue to show renewed price strength and hit that benchmark.

How To Invest In Stocks In Both Bull And Bear Markets

Is Inari Medical Stock A Buy?

Inari Medical stock is now considered extended and out of buy range after clearing a 53.67 buy point in a first-stage cup with handle. See if the medical stock forms a new pattern or follow-on buying opportunity like a three-weeks tight or pullback to the 50-day or 10-week moving average.

The medical device company posted 0% earnings growth in the latest quarterly report. Revenue rose 21%.

Inari Medical stock earns the No. 50 rank among its peers in the Medical-Products industry group. Globus Medical (GMED), LeMaitre Vascular (LMAT) and Insulet (PODD) are among the top 5 highly rated stocks within the group.

YOU MAY ALSO LIKE:

MarketSurge's Tools Can Help The Individual Investor

IBD Live: A New Tool For Daily Stock Market Analysis

Profit From Short-Term Trends With SwingTrader

How To Research Growth Stocks: Why This IBD Tool Simplifies The Search For Top Stocks

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2490815783"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2490815783\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2490815783?lang=zh_CN&edition=fundamental","thumbnail":"https://www.investors.com/wp-content/uploads/2017/05/IRU6-150x150.jpg","is_english":true,"pubTime":"2024-12-12 03:59","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2490815783","market":"us","top_or_hot":-1,"title":"Inari Medical Stock Gets RS Rating Upgrade","media":"Blockhead","content":"<html><body><div>\n<p>On Wednesday, <b>Inari Medical</b> (NARI) stock received an upgrade to its Relative Strength (RS) Rating, from 65 to 72.</p>\n<span>\n<span>\n<span jw-video-key=\"6xjZJt10\" vid-authors=\"RACHEL FOX\" vid-cat=\"Investor's Corner\" vid-date=\"11/19/2024\" vid-date-tmsp=\"1732025282\" vid-dom-id=\"9524406-675a09194e6a9\" vid-id=\"9524406\" vid-image=\"https://www.investors.com/wp-content/uploads/2024/11/6xjZJt10-640x360.jpg\" vid-name=\"RS Line vs. RS Rating: Which Is The Better Stock Indicator?\" vid-repeat=\"1\" vid-top=\"\" vid-url=\"https://content.jwplatform.com/manifests/6xjZJt10.m3u8\" vid-width=\"50\">\n<span>↑</span>\n<span>X</span>\n<span>\n<span></span>\n<div>\n<div>\nRS Line vs. RS Rating: Which Is The Better Stock Indicator?\n</div>\n<div>\nSee All Videos\n</div>\n</div>\n</span>\n<span>\n<span>NOW PLAYING</span>\n<span>RS Line vs. RS Rating: Which Is The Better Stock Indicator?</span>\n</span>\n</span>\n</span>\n</span>\n<p>This proprietary rating measures technical performance by showing how a stock's price action over the last 52 weeks compares to that of the other stocks in our database.</p>\n<p>Over 100 years of market history shows that the best-performing stocks tend to have an RS Rating north of 80 as they launch their largest climbs. See if Inari Medical stock can continue to show renewed price strength and hit that benchmark.</p>\n<hr/>\n<p>How To Invest In Stocks In Both Bull And Bear Markets</p>\n<hr/>\n<h2>Is Inari Medical Stock A Buy?</h2>\n<p>Inari Medical stock is now considered extended and out of buy range after clearing a 53.67 buy point in a first-stage cup with handle. See if the medical stock forms a new pattern or follow-on buying opportunity like a three-weeks tight or pullback to the 50-day or 10-week moving average.</p>\n<div><div></div></div>\n<p>The medical device company posted 0% earnings growth in the latest quarterly report. Revenue rose 21%.</p>\n<p>Inari Medical stock earns the No. 50 rank among its peers in the Medical-Products industry group. <b>Globus Medical</b> (GMED), <b>LeMaitre Vascular</b> (LMAT) and <b>Insulet</b> (PODD) are among the top 5 highly rated stocks within the group.</p>\n<p><strong>YOU MAY ALSO LIKE:</strong></p>\n<p><span>MarketSurge's Tools Can Help The Individual Investor</span></p>\n<p><span>IBD Live: A New Tool For Daily Stock Market Analysis</span></p>\n<p><span>Profit From Short-Term Trends With SwingTrader</span></p>\n<p><span>How To Research Growth Stocks: Why This IBD Tool Simplifies The Search For Top Stocks</span></p>\n</div></body></html>","source":"investor_business_daily_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Inari Medical Stock Gets RS Rating Upgrade</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nInari Medical Stock Gets RS Rating Upgrade\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-12-12 03:59 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.investors.com/news/inari-medical-stock-gets-rs-rating-upgade/><strong>Blockhead</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>On Wednesday, Inari Medical (NARI) stock received an upgrade to its Relative Strength (RS) Rating, from 65 to 72.\n\n\n\n↑\nX\n\n\n\n\nRS Line vs. RS Rating: Which Is The Better Stock Indicator?\n\n\nSee All ...</p>\n\n<a href=\"https://www.investors.com/news/inari-medical-stock-gets-rs-rating-upgade/\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"RS","symbol_name":"Reliance Steel & Aluminum Co","start_time":0,"source_url":"https://www.investors.com/news/inari-medical-stock-gets-rs-rating-upgade/","article_id":"2490815783","we_media_id":null,"thumbnails":["https://www.investors.com/wp-content/uploads/2017/05/IRU6-150x150.jpg"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2490815783","pubTimestamp":1733947140,"columns":[],"sourceInfo":{"source_id":"investor_business_daily_highlight","name":"Investor’s Business Daily"},"weMediaInfo":null,"summary":"Inari Medical shows improving price performance, earning an upgrade to its IBD Relative Strength Rating","collect":0,"end_time":0,"defaultTopTitle":"investors.com","property":["rate"],"viewcount":null,"language":"en","relate_stocks":{"RS":"Reliance Steel & Aluminum Co","NARI":"Inari Medical, Inc."},"translate_title":"伊那里医疗股票获得RS评级升级","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NARI":1,"RS":1},"content_text":"On Wednesday, Inari Medical (NARI) stock received an upgrade to its Relative Strength (RS) Rating, from 65 to 72.\n\n\n\n↑\nX\n\n\n\n\nRS Line vs. RS Rating: Which Is The Better Stock Indicator?\n\n\nSee All Videos\n\n\n\n\nNOW PLAYING\nRS Line vs. RS Rating: Which Is The Better Stock Indicator?\n\n\n\n\nThis proprietary rating measures technical performance by showing how a stock's price action over the last 52 weeks compares to that of the other stocks in our database.\nOver 100 years of market history shows that the best-performing stocks tend to have an RS Rating north of 80 as they launch their largest climbs. See if Inari Medical stock can continue to show renewed price strength and hit that benchmark.\n\nHow To Invest In Stocks In Both Bull And Bear Markets\n\nIs Inari Medical Stock A Buy?\nInari Medical stock is now considered extended and out of buy range after clearing a 53.67 buy point in a first-stage cup with handle. See if the medical stock forms a new pattern or follow-on buying opportunity like a three-weeks tight or pullback to the 50-day or 10-week moving average.\n\nThe medical device company posted 0% earnings growth in the latest quarterly report. Revenue rose 21%.\nInari Medical stock earns the No. 50 rank among its peers in the Medical-Products industry group. Globus Medical (GMED), LeMaitre Vascular (LMAT) and Insulet (PODD) are among the top 5 highly rated stocks within the group.\nYOU MAY ALSO LIKE:\nMarketSurge's Tools Can Help The Individual Investor\nIBD Live: A New Tool For Daily Stock Market Analysis\nProfit From Short-Term Trends With SwingTrader\nHow To Research Growth Stocks: Why This IBD Tool Simplifies The Search For Top Stocks","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1}}}